Developing medicines for agitation and aggression in Alzheimer's disease

Publisher： Cambridge University Press

E-ISSN： 1741-203x|27|2|179-179

ISSN： 1041-6102

Source： International Psychogeriatrics, Vol.27, Iss.2, 2014-12, pp. : 179-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease

By  

International Psychogeriatrics, Vol. 25, Iss. 5, 2013-05 ,pp. : 707-719

Cambridge University Press

Access to resources Recommend Favorite

Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design

By  

International Psychogeriatrics, Vol. 27, Iss. 2, 2015-02 ,pp. : 181-197

Cambridge University Press

Access to resources Recommend Favorite

Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial

By  

International Psychogeriatrics, Vol. 27, Iss. 12, 2015-12 ,pp. : 2059-2067

Cambridge University Press

Access to resources Recommend Favorite

Predictors of nursing home admission among Alzheimer's disease patients with psychosis and/or agitation

By  

International Psychogeriatrics, Vol. 23, Iss. 1, 2011-02 ,pp. : 44-53

Cambridge University Press

Access to resources Recommend Favorite

TOP CITED PAPERS IN INTERNATIONAL PSYCHOGERIATRICS: 4. EFFECTS OF INDIVIDUALIZED VS. CLASSICAL “RELAXATION” MUSIC ON THE FREQUENCY OF AGITATION IN ELDERLY PERSONS WITH ALZHEIMER'S DISEASE AND RELATED DISORDERS

By  

International Psychogeriatrics, Vol. 21, Iss. 4, 2009-08 ,pp. : 667-671

Cambridge University Press

Access to resources Recommend Favorite